InicioSNY • NASDAQ
add
Sanofi
Cierre anterior
50,21 $
Intervalo diario
49,08 $ - 49,84 $
Intervalo anual
42,63 $ - 55,72 $
Cap. bursátil
125,11 mil M USD
Volumen medio
2,27 M
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (EUR) | mar 2024info | Cambio interanual |
|---|---|---|
Ingresos | 11,12 mil M | 2,35 % |
Gastos operativos | 5647,00 M | 13,78 % |
Ingresos netos | 1133,00 M | -43,21 % |
Margen de beneficio neto | 10,19 | -44,50 % |
Beneficios por acción | 1,78 | 49,21 % |
EBITDA | 2861,50 M | -20,00 % |
Tipo impositivo efectivo | 12,52 % | — |
Balance general
Activos totales
Responsabilidades totales
| (EUR) | mar 2024info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 8710,00 M | -31,61 % |
Activos totales | — | — |
Responsabilidades totales | — | — |
Patrimonio total | 74,35 mil M | — |
Acciones en circulación | 1248,56 M | — |
Precio-valor contable | 0,85 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 5,48 % | — |
Flujo de caja
Variación neta del flujo de caja
| (EUR) | mar 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | 1133,00 M | -43,21 % |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. Wikipedia
Director ejecutivo
Fundación
1973
Sitio web
Empleados
86.088
